Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Operations (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Cash from Operations data on record, last reported at 1044000.0 in Q1 2013.

  • For Q1 2013, Cash from Operations rose 20.55% year-over-year to 1044000.0; the TTM value through Mar 2013 reached 1150000.0, up 128.52%, while the annual FY2025 figure was 88000.0, 96.33% up from the prior year.
  • Cash from Operations reached 1044000.0 in Q1 2013 per SNOA's latest filing, up from 1098000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4556000.0 in Q3 2012 and bottomed at 1633000.0 in Q4 2010.
  • Average Cash from Operations over 4 years is 609250.0, with a median of 1163000.0 recorded in 2010.
  • The widest YoY moves for Cash from Operations: up 585.2% in 2012, down 1675.68% in 2012.
  • A 4-year view of Cash from Operations shows it stood at 1633000.0 in 2010, then grew by 23.45% to 1250000.0 in 2011, then rose by 12.16% to 1098000.0 in 2012, then rose by 4.92% to 1044000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 1044000.0 in Q1 2013, 1098000.0 in Q4 2012, and 4556000.0 in Q3 2012.